GeorgeSSchroederMD

PubMed

• 56 citations
  Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis
  Animesh Pardanani, Thomas E. Witzig, Georgene Schroeder, Edwin A. McElroy, Rafael Fonseca, Angela Dispenzieri, Martha Q. Lacy, John A. Lust, Robert A. Kyle, Philip R. ...> ;Blood. 2003 Feb 1
• 12 citations
  Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of t...
  Mark R. Litzow, Panagiotis Repoussis, Georgene Schroeder, David Schembri-Wismayer, Kenneth P. Batts, Peter M. Anderson, Carola A.S. Arndt, M G Chen, Dennis A. Gastinea...> ;Leukemia & Lymphoma. 2002 Nov 1
• 238 citations
  Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
  S. Vincent Rajkumar, Ruben A. Mesa, Rafael Fonseca, Georgene Schroeder, Matthew F. Plevak, Angela Dispenzieri, Martha Q. Lacy, John A. Lust, Thomas E. Witzig, Morie A....> ;Clinical Cancer Research. 2002 Jul 1
• Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial.
  Weeks, J. C., Nelson, H., Gelber, S., Sargent, D., Schroeder, G.> ;JAMA. 2002 Jan 16
• Characteristics of patients with vaginal rupture and evisceration.
  Croak, A. J., Gebhart, J. B., Klingele, C. J., Schroeder, G., Lee, R. A., Podratz, K. C.> ;Obstet Gynecol. 2004 Mar
• Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome.
  Steensma, D. P., Dispenzieri, A., Moore, S. B., Schroeder, G., Tefferi, A.> ;Blood. 2003 Mar 15
• A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.
  Mesa, R. A., Tefferi, A., Elliott, M. A., Hoagland, H. C., Call, T. G., Schroeder, G. S., Yoon, S. Y., Li, C. Y., Gray, L. A., Margolin, S., Hook, C. C.> ;Br J Haematol. 2001 Jul
• Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia.
  Mesa, R. A., Hanson, C. A., Li, C. Y., Yoon, S. Y., Rajkumar, S. V., Schroeder, G., Tefferi, A.> ;Blood. 2002 Jun 1
• Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.
  Mesa, R. A., Elliott, M. A., Schroeder, G., Tefferi, A.> ;Mayo Clin Proc. 2004 Jul
• A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia.
  Mesa, R. A., Steensma, D. P., Pardanani, A., Li, C. Y., Elliott, M., Kaufmann, S. H., Wiseman, G., Gray, L. A., Schroeder, G., Reeder, T., Zeldis, J. B., Tefferi, A.> ;Blood. 2003 Apr 1
• Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
  Tefferi, A., Mesa, R. A., Gray, L. A., Steensma, D. P., Camoriano, J. K., Elliott, M. A., Pardanani, A., Ansell, S. M., Call, T. G., Colon-Otero, G., Schroeder, G., Ha...> ;Blood. 2002 May 15
• Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.
  Mesa, R. A., Li, C. Y., Ketterling, R. P., Schroeder, G. S., Knudson, R. A., Tefferi, A.> ;Blood. 2005 Feb 1
• Join now to see all